Australian Clinical Labs offers to buy Healius for $1 billion (updated)

Australian Clinical Labs

19/03/2023 22:18

(Updates with further details and background)
       March 20 (Reuters) - Australian Clinical Labs  ACL.AX 
said on Monday it will acquire Healius  HLS.AX  through an
all-share takeover, valuing the medical center operator at
A$1.52 billion ($1.02 billion). 
    The pathology firm said it will offer 0.74 share for every
Healius share. The offer price represents a discount of about
4.2% to Healius' last close. 
    If the deal is successful, Healius' shareholder will own 68%
of the merged entity, the company said in a statement. 
    In 2020, Healius rejected a $1.3 billion buyout offer from
Partners Group, saying at the time it undervalued the medical
center operator.           

 ($1 = 1.4896 Australian dollars)

 (Reporting by Navya Mittal in Bengaluru; Editing by Lisa
Shumaker)
 ((Navya.Mittal@thomsonreuters.com;))